Prairie Isotope Production Enterprise

Acsion is a founding partner of PIPE (, a not-for-profit corporation based in Manitoba. Our goal is to develop a reliable supply of the medical radioisotope technetium-99m (Tc-99m) for Canadian patients.

Tc-99m, which is obtained from the decay of its parent isotope molybdenum-99 (Mo-99), is the most widely used medical isotope for medical imaging and accounts for approximately 80% of nuclear medicine diagnostic procedures in Canada. Mo-99 is currently produced by a small number of research reactors around the world including the National Research Universal (NRU) reactor at Chalk River Laboratories in Ontario.

PIPE’s technology uses an electron accelerator rather than a nuclear reactor to make the Mo-99. The electron accelerator, a radiation generating machine that accelerates electrons to very high energies, sprays electricity onto molybdenum metal, which produces the Mo-99 radioisotope. Next, a chemical process is used to fabricate the Tc-99m compounds for hospitals and clinics across the country.

Our process has no radioactive wastes that need to be managed like the current production methods that use uranium as a starting material. In fact, this process includes recycling where everything comes back to PIPE to be used again.

PIPE was formed to insure the application of this technology to the provision of a solution in creating a reliable supply of Tc-99m for Canadian patients.